A Phase 1a/1b, Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK112 in Subjects with Advanced Solid Tumors

  • Frentzas, Sophia (Primary Chief Investigator (PCI))
  • Parakh, Sagun (Primary Chief Investigator (PCI))
  • Frentzas, Sophia (Primary Chief Investigator (PCI))
  • Body, Amy (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date15/11/19 → 14/11/24

Keywords

  • phase 1 study
  • clinical trial
  • treatment efficacy
  • solid tumour